[Effect of a bacterial lysate (Broncho-Vaxom) in the therapy of chronic bronchitis: multi-center double-blind clinical trial]. 1981

C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux

UI MeSH Term Description Entries
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002457 Cell Extracts Preparations of cell constituents or subcellular materials, isolates, or substances. Cell Extract,Extract, Cell,Extracts, Cell
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
June 1984, Praxis und Klinik der Pneumologie,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
June 1984, Schweizerische medizinische Wochenschrift,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
January 1988, ORL; journal for oto-rhino-laryngology and its related specialties,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
January 1989, Therapia Hungarica (English edition),
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
November 1989, International journal of clinical pharmacology, therapy, and toxicology,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
January 1985, International journal of immunopharmacology,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
September 2023, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
February 1980, Die Medizinische Welt,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
March 1996, Allergie et immunologie,
C Messerli, and F Michetti, and P Sauser-Hall, and C Stäubli, and M Taddei, and S Weiss, and J C Farine, and T Fux
May 2016, European review for medical and pharmacological sciences,
Copied contents to your clipboard!